| Literature DB >> 25526695 |
N Sanoj Rejinold1, Reju George Thomas2, Muthunarayanan Muthiah3, K P Chennazhi1, K Manzoor1, In-Kyu Park4, Yong Yeon Jeong2, R Jayakumar5.
Abstract
The curcumin-encapsulated chitosan-graft-poly(N-vinyl caprolactam) nanoparticles containing gold nanoparticles (Au-CRC-TRC-NPs) were developed by ionic cross-linking method. After "optimum RF exposure" at 40 W for 5 min, Au-CRC-TRC-NPs dissipated heat energy in the range of ∼42°C, the lower critical solution temperature (LCST) of chitosan-graft-poly(N-vinyl caprolactam), causing controlled curcumin release and apoptosis to cancer cells. Further, in vivo PK/PD studies on swiss albino mice revealed that Au-CRC-TRC-NPs could be sustained in circulation for a week with no harm to internal organs. The colon tumor localization studies revealed that Au-CRC-TRC-NPs were retained in tumor for a week. These results throw light on their feasibility as multi-responsive nanomedicine for RF-assisted cancer treatment modalities.Entities:
Keywords: Chitosan-graft-PNVCL; Curcumin; Gold; RF therapy; Tumor localization
Mesh:
Substances:
Year: 2014 PMID: 25526695 DOI: 10.1016/j.ijbiomac.2014.11.044
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953